Related Experiment Video
Updated: Aug 29, 2026

Characterization and Functional Prediction of Bacteria in Ovarian Tissues
Published on: October 23, 2021
The role of human microbiota in breast cancer pathogenesis and treatment
Jie Qiu1,2, Xiaojia Wang3, Man Li4
1Department of Breast and Thyroid Surgery Shaoxing People's Hospital Shaoxing Zhejiang China.
Abstract:
The human microbiota contributes to breast cancer pathogenesis and treatment response through interactions involving the oral, gut, and breast microbial niches. (Left) Multi-site dysbiosis is characterized by altered microbial composition and abundance across different anatomical sites. (Middle) Microbial components and metabolites influence tumor progression and the tumor microenvironment through mechanisms including immune, metabolic, and inflammatory regulation. (Right) The microbiota and their metabolites further affect therapeutic efficacy and toxicity in immunotherapy, chemotherapy, endocrine therapy, and human epidermal growth factor receptor 2 (HER2)-targeted therapy, highlighting the translational potential of microbiota-targeted strategies in breast cancer.
Related Concept Videos
Introduction to the Human Microbiota
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Functions of the Gut Microbiota
Dysbiosis of the Gut Microbiota
The Skin Microbiota

